TASECTAN® is licensed as a medical device. TASECTAN® has a dual mechanism of action to restore the physiological functions of the gut wall: it traps and inhibits the pro-inflammatory proteins and acts as an astringent.
TASECTAN® is a combination of tannic acid and gelatine.
TASECTAN® is marketed in capsules as gelatine tannate 500 mg for adults and in sachets (gelatine tannate 250 mg) recommended for paediatric use.
Approval or registration is pending in more than 40 countries around the world (Europe, Latin America, Africa and Asia).
Click on the button below if you are a Healthcare Professional and accept the following conditions:The information contained in this site is exclusively intended for Healthcare Professionals who are duly authorised to prescribe or sell pharmaceutical products. Special training is required for the correct interpretation of this information. If you are not a qualified Healthcare Professional, Novintethical will not assume any responsibility for any damages derived from decisions based on the information contained herein or in related links.
Remember that it is a restricted access website you will only be able to access by validating a user code and password that will have been supplied to you beforehand by Novintethical.
Please close your browser when you are through with your session to prevent unauthorized access to the information. |
|
 |
